ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,135, issued on Jan. 28, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).
"Formulations of dengue virus vaccine compositions" was invented by Michael S. Ryan (Allentown, Pa.), Sherrie-Ann P. Martin (Paoli, Pa.), Morrisa Jones (Upper Darby, Pa.), Justin Stanbro (Sellersville, Pa.), Akhilesh Bhambhani (Doylestown, Pa.), Jeffrey Thomas Blue (Telford, Pa.), Heidi Joanne Pixley (Glenside, Pa.), Erin J. Green-Trexler (Green Lane, Pa.) and Lynne Ann Isopi (Quakertown, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to formulations of dengue virus vaccine comprising at least one live, attenuated dengue virus or live, a...